{"doi":"10.1038/s41591-021-01623-z","title":"T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma","abstract":null,"journal":"Nature Medicine","year":2022,"id":13499,"datarank":7.919176903912886,"base_score":5.75890177387728,"endowment":5.75890177387728,"self_citation_contribution":0.8638352660815922,"citation_network_contribution":7.055341637831294,"self_endowment_contribution":0.8638352660815922,"citer_contribution":7.055341637831294,"corpus_percentile":98.5,"corpus_rank":null,"citation_count":316,"citer_count":194,"citers_with_citation_signal":194,"citers_with_endowment":194,"datacite_reuse_total":25,"is_dataset":false,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"authors":[{"id":110534,"name":"Aadel A. Chaudhuri","orcid":"0000-0003-3115-3061","position":1,"is_corresponding":false},{"id":110535,"name":"Aishwarya Nene","orcid":"0000-0002-5160-5080","position":2,"is_corresponding":false},{"id":110536,"name":"Antonietta Bacchiocchi","orcid":null,"position":3,"is_corresponding":false},{"id":110537,"name":"Noah Earland","orcid":null,"position":4,"is_corresponding":false},{"id":110538,"name":"Matthew D. Vesely","orcid":"0000-0001-9363-945X","position":5,"is_corresponding":false},{"id":110539,"name":"Abul Usmani","orcid":"0000-0001-5485-7323","position":6,"is_corresponding":false},{"id":110540,"name":"Brandon E. Turner","orcid":null,"position":7,"is_corresponding":false},{"id":110541,"name":"Chloé B. Steen","orcid":"0000-0001-7290-7128","position":8,"is_corresponding":false},{"id":110542,"name":"Bogdan A. Luca","orcid":null,"position":9,"is_corresponding":false},{"id":110543,"name":"Ti Badri","orcid":"0000-0002-9869-7541","position":10,"is_corresponding":false},{"id":110544,"name":"Gunsagar S. Gulati","orcid":"0000-0003-2798-6220","position":11,"is_corresponding":false},{"id":110545,"name":"Milad R. Vahid","orcid":null,"position":12,"is_corresponding":false},{"id":110546,"name":"Farnaz Khameneh","orcid":null,"position":13,"is_corresponding":false},{"id":110547,"name":"Peter K. Harris","orcid":null,"position":14,"is_corresponding":false},{"id":110548,"name":"David Y. Chen","orcid":"0000-0002-3681-6576","position":15,"is_corresponding":false},{"id":110549,"name":"Kavita Dhodapkar","orcid":null,"position":16,"is_corresponding":false},{"id":68933,"name":"Mario Sznol","orcid":"0000-0002-4359-8749","position":17,"is_corresponding":false},{"id":110550,"name":"Ruth Halaban","orcid":"0000-0001-8451-1964","position":18,"is_corresponding":false},{"id":17223,"name":"Aaron M. Newman","orcid":"0000-0002-1857-8172","position":19,"is_corresponding":false},{"id":110533,"name":"Alexander X. Lozano","orcid":"0000-0001-8424-291X","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":5.75890177387728,"endowment":5.75890177387728,"datacite_reuse_total":25,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"35027754","pmcid":"PMC8866214","openalex_id":"https://openalex.org/W4206697524","authors":[],"funders":[{"funder_name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","grant_id":"R00CA187192","title":null},{"funder_name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","grant_id":"1K08CA238711","title":null},{"funder_name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","grant_id":"K08CA237727","title":null},{"funder_name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","grant_id":"R01CA238471","title":null},{"funder_name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","grant_id":"R21CA218950","title":null},{"funder_name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","grant_id":"T35HL007649","title":null},{"funder_name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","grant_id":"R01AR077926","title":null},{"funder_name":"NCATS NIH HHS","grant_id":"KL2 TR001862","title":null},{"funder_name":"NCI NIH HHS","grant_id":"K08 CA238711","title":null},{"funder_name":"NCATS NIH HHS","grant_id":"UL1 TR001863","title":null},{"funder_name":"NIGMS NIH HHS","grant_id":"T32 GM007200","title":null},{"funder_name":"Natural Sciences and Engineering Research Council of Canada","grant_id":"unidentified","title":"unidentified"},{"funder_name":"National Institutes of Health","grant_id":"5R01CA238471-02","title":"B cells in autoimmunity following checkpoint blockade therapy"},{"funder_name":"National Institutes of Health","grant_id":"5R21CA218950-02","title":"Integrative genomic biomarkers for predicting response to immunotherapy in melanoma patients"},{"funder_name":"National Institutes of Health","grant_id":"5R00CA187192-04","title":"Ultrasensitive Quantitation of Circulating Tumor DNA"},{"funder_name":"National Institutes of Health","grant_id":"5R01AR077926-02","title":"B cell depletion to prevent autoimmunity"},{"funder_name":"National Institutes of Health","grant_id":"2T35HL007649-31","title":"Short Term Research Training:  Students in Health Professional Schools"},{"funder_name":"National Institutes of Health","grant_id":"1K08CA238711-01","title":"Cell-Free Nucleic Acids for Early Treatment Response Assessment of Hepatocellular Cancer"},{"funder_name":"National Institutes of Health","grant_id":"5K08CA237727-04","title":"Epigenetic Regulation of Cutaneous Tumorigenesis"},{"funder_name":"Washington University Alvin J. Siteman Cancer Research Fund","grant_id":"","title":null},{"funder_name":"Yale Cancer Center","grant_id":"","title":null},{"funder_name":"Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada","grant_id":"","title":null},{"funder_name":"V Foundation for Cancer Research","grant_id":"","title":null},{"funder_name":"Yale Cancer Center10x Genomics Pilot Program Award","grant_id":"","title":null},{"funder_name":"Virginia and D.K. Ludwig Fund for Cancer Research","grant_id":"","title":null},{"funder_name":"Cancer Research Foundation","grant_id":"","title":null},{"funder_name":"Donald E. and Delia B. Baxter Foundation","grant_id":"","title":null},{"funder_name":"Stinehart-Reed FoundationStanford Bio-X Interdisciplinary Initiatives","grant_id":"","title":null}],"total_grants":28,"fwci":33.2592,"citation_percentile":0.99809951,"influential_citations":11,"citation_trend":[{"year":2022,"count":51},{"year":2023,"count":72},{"year":2024,"count":110},{"year":2025,"count":65},{"year":2026,"count":18}],"oa_status":"green","license":"Springer TDM","oa_locations":[{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8866214","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866214","host_type":"GREEN"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8866214","host_type":"repository"},{"url":"https://www.nature.com/articles/s41591-021-01623-z.pdf","host_type":"publisher"},{"url":"https://www.nature.com/articles/s41591-021-01623-z","host_type":"publisher"},{"url":"https://doi.org/10.1038/s41591-021-01623-z","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/35027754","host_type":"repository"}],"fields_of_study":["Cancer Immunotherapy and Biomarkers","CAR-T cell therapy research","Immunotherapy and Immune Responses","Medicine","0301 basic medicine","0303 health sciences","03 medical and health sciences","Humans","Immune Checkpoint Inhibitors","Melanoma","Retrospective Studies","T-Lymphocytes"],"mesh_terms":["Immune Checkpoint Inhibitors","Humans","Melanoma","Retrospective Studies","T-Lymphocytes"],"keywords":["Blockade","Melanoma","Immune checkpoint","Toxicity","Medicine","Immune system","Cancer research","Immunology","Immunotherapy","Internal medicine","Receptor","T-Lymphocytes","Humans","Immune Checkpoint Inhibitors","Retrospective Studies"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.24209135.v1","title":"Additional file 1 of Disulfidptosis-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinoma","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.24209135","title":"Additional file 1 of Disulfidptosis-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinoma","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25367407.v1","title":"Additional file 1 of S100A9+CD14+ monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25367407","title":"Additional file 1 of S100A9+CD14+ monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25367515.v1","title":"Additional file 2 of S100A9+CD14+ monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25367515","title":"Additional file 2 of S100A9+CD14+ monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26553032.v1","title":"Additional file 1 of Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26553032","title":"Additional file 1 of Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26630104.v1","title":"Additional file 1 of Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26630104","title":"Additional file 1 of Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26630107.v1","title":"Additional file 2 of Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26630107","title":"Additional file 2 of Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26630110.v1","title":"Additional file 3 of Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26630110","title":"Additional file 3 of Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26630116.v1","title":"Additional file 4 of Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26630116","title":"Additional file 4 of Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26630119.v1","title":"Additional file 5 of Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26630119","title":"Additional file 5 of Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26630125.v1","title":"Additional file 7 of Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26630125","title":"Additional file 7 of Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26630128.v1","title":"Additional file 8 of Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26630128","title":"Additional file 8 of Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26630131.v1","title":"Additional file 9 of Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26630131","title":"Additional file 9 of Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26630134.v1","title":"Additional file 10 of Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[{"name":"doi"}],"source":"live","citation_network_status":"fetched"},"created_at":"2026-04-13T19:31:23.598840Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}